Inventor · disambiguated record
Sven Erik Godtfredsen
Also filed as: GODTFREDSEN SVEN · GODTFREDSEN SVEN E · GODTFREDSEN SVEN ERIK
16 granted patents·10 pending applications·365 citations·filing 1981–2024
93Inventor score
Top patents by PatentIndex Score
26 records- 0196US8877938B2Compounds containing S-N-valeryl-N-{[2′-(1H-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2R,4S)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and cationsFENG LILI·Filed 2006·Granted Nov 4, 2014·44 cites·14 claims
- 0293US6110676AMethods for suppressing the binding of detectable probes to non-target sequences in hybridization assaysBOSTON PROBES INC·Filed 1997·Granted Aug 29, 2000·240 cites·41 claims
- 0391US2025339395A1Compounds containing s-n-valeryl-n-{[2'-(1h-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2r,4s)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and cationsNOVARTIS PHARMACEUTICALS CORP·Filed 2024·Application pending·0 cites
- 0486US9388134B2Compounds containing S-N-valeryl-N-{[2′-(1H-tetrazole-5-yl)-biphenyl-4-yl]-methyl)-valine and (2R,4S)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and cationsFENG LILI·Filed 2014·Granted Jul 12, 2016·5 cites·15 claims
- 0584US11642329B2Amorphous solid form of compounds containing S—N-valeryl-N- {[2′-( 1 H-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2R,4S)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and sodium cationsNOVARTIS PHARMACEUTICALS CORP·Filed 2022·Granted May 9, 2023·0 cites·2 claims
- 0683US2022257551A1Amorphous solid form of compounds containing s-n-valeryl-n-{[2'-(1h-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2r,4s)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and sodium cationsNOVARTIS PHARMACEUTICALS CORP·Filed 2022·Application pending·0 cites
- 0781US11096918B2Amorphous solid form of compounds containing S—N-valeryl-N-{[2′-(1H-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2R,4S)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and sodium cationsNOVARTIS PHARMACEUTICALS CORP·Filed 2019·Granted Aug 24, 2021·0 cites·2 claims
- 0879US6962778B1Methods, kits and compositions for suppressing the binding of detectable probes to non-target sequences in hybridization assaysBOSTON PROBES INC·Filed 2000·Granted Nov 8, 2005·10 cites·41 claims
- 0979US2021361610A1Compounds containing s-n-valeryl-n-{[2'-(1h-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2r,4s)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and cationsNOVARTIS PHARMACEUTICALS CORP·Filed 2021·Application pending·0 cites
- 1074US5200328AProcess for producing methyl glycoside estersNOVO NORDISK AS·Filed 1990·Granted Apr 6, 1993·15 cites·11 claims
- 1172US2019374498A1Compounds containing s-n-valeryl-n-{[2'-(1h-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2r,4s)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and cationsNOVARTIS AG·Filed 2019·Application pending·0 cites
- 1272US2019374497A1Compounds containing s-n-valeryl-n-{[2'-(1h-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2r,4s)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and cationsNOVARTIS AG·Filed 2019·Application pending·0 cites
- 1370US10668035B2Substituted bisphenyl butanoic ester derivatives as NEP inhibitorsNOVARTIS AG·Filed 2019·Granted Jun 2, 2020·1 cites·21 claims
- 1469US2018344679A1Compounds containing s-n-valeryl-n-{[2'-(1h-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2r,4s)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and cationsNOVARTIS AG·Filed 2018·Application pending·0 cites
- 1562US11426375B2Substituted bisphenyl butanoic ester derivatives as NEP inhibitorsNOVARTIS AG·Filed 2020·Granted Aug 30, 2022·0 cites·26 claims
- 1662US2016324821A1Compounds containing s-n-valeryl-n--valine and (2r,4s)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and cationsFENG LILI·Filed 2016·Application pending·0 cites
- 1753US2003124521A1Methods, kits and compositions for supressing the binding of detectable probes to non-target sequences in hybridization assaysFiled 2000·Application pending·0 cites
- 1850US5191071AMonoesters of glycosides and a process for enzymatic preparation thereofNOVO NORDISK AS·Filed 1991·Granted Mar 2, 1993·16 cites·38 claims
- 1948US4859589AEnzymatic method for preparation of epoxy compoundsNOVO INDUSTRI AS·Filed 1987·Granted Aug 22, 1989·5 cites·11 claims
- 2048US4708875AProduction of fermented alcoholic products having a low diacetyl contentFORENEDE BRYGGERIER AS·Filed 1981·Granted Nov 24, 1987·14 cites·11 claims
- 2143US2013158088A1Treatment of hypertension and/or prevention or treatment of heart failure in a mammal receiving anti-coagulant therapyALBRECHT DIEGO·Filed 2011·Application pending·0 cites
- 2241US5534435AProcess for decomposing peroxycarboxylic acidsNOVO NORDISK AS·Filed 1995·Granted Jul 9, 1996·2 cites·7 claims
- 2341US2014329872A1Treatment of hypertension and/or prevention or treatment of heart failure in a mammal receiving anti-coagulant therapyALBRECHT DIEGO JOCHEN·Filed 2014·Application pending·0 cites
- 2440US5541092AProcess for preparing peroxycarboxylic acids using lipase in a non-aqueous mediumNOVO NORDISK AS·Filed 1994·Granted Jul 30, 1996·3 cites·19 claims
- 2537US5116744AMicrobial cyanide converting enzymes, their production and useNOVO INDUSTRI AS·Filed 1990·Granted May 26, 1992·10 cites·20 claims
- 2624US10596151B2Methods and pharmaceutical compositions for reducing arterial stiffness with a combination of a therapeutic agent blocking the angiotensin receptor and a therapeutic agent inhibiting the NEP enzymeGODTFREDSEN SVEN ERIK·Filed 2016·Granted Mar 24, 2020·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Sven Erik Godtfredsen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →